Imigran Injection/Subject - syringes may have needles protruding from the needle shield

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!

Imigran Injection/Subject - syringes may have needles protruding from the needle shield

2014-12-17 15:02:24 (11 year(s) ago)

Summary

(GlaxoSmithKline UK) Remaining stocks of the affected batch should be quarantined and returned to the original supplier for credit – class 2 action within 48 hours. (EL (13)A/26)

Read full MHRA article

Respond to this alert